Cited by 592Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Open access

Korenblat, Kevin M., Fabbrini, Elisa, Mohammed, B. Selma, Klein, Samuel·2008·Gastroenterology

DOI 10.1053/j.gastro.2008.01.075PMC PMC2629391

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Nonalcoholic fatty liver disease is associated with insulin resistance and diabetes. The purpose of this study was to determine the relationship between intrahepatic triglyceride (IHTG) content and insulin action in liver (suppression of glucose production), skeletal muscle (stimulation of glucose uptake), and adipose tissue (suppression of lipolysis) in nondiabetic obese subjects.Methods A euglycemic-hyperinsulinemic clamp procedure and stable isotopically labeled tracer infusions were used to assess insulin action, and magnetic resonance spectroscopy was used to determine IHTG content, in 42 nondiabetic obese subjects (body mass index, 36 +/- 4 kg/m(2)) who had a wide range of IHTG content (1%-46%).Results Hepatic insulin sensitivity, assessed as a function of glucose production rate and plasma insulin concentration, was inversely correlated with IHTG content (r = -0.599; P < .001). The ability of insulin to suppress fatty acid release from adipose tissue and to stimulate glucose uptake by skeletal muscle were also inversely correlated with IHTG content (adipose tissue: r = -0.590, P < .001; skeletal muscle: r = -0.656, P < .001). Multivariate linear regression analyses found that IHTG content was the best predictor of insulin action in liver, skeletal muscle, and adipose tissue, independent of body mass index and percent body fat, and accounted for 34%, 42%, and 44% of the variability in these tissues, respectively (P < .001 for each model).Conclusions These results show that progressive increases in IHTG content are associated with progressive impairment of insulin action in liver, skeletal muscle, and adipose tissue in nondiabetic obese subjects. Therefore, nonalcoholic fatty liver disease should be considered part of a multiorgan system derangement in insulin sensitivity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.01.075

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Michigan Alcoholism Screening Test: The Quest for a New Diagnostic Instrument
Selzer, M. L. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1653 · Cited by 3,431
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,728
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658

Flagged first, then by citations

Show all 41 references

Sorted by citations

Items 101–200 of 592

Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review
Petäjä, E. M., & Yki‐Järvinen, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050633 · Cited by 144
Ethnic Differences in Pancreatic Fat Accumulation and Its Relationship With Other Fat Depots and Inflammatory Markers
Lê, K., Ventura, E. E., Fisher, J. Q., Davis, J. N., Weigensberg, M. J., Punyanitya, M., Hu, P., Nayak, K. S., & Goran, M. I. (2011) · Diabetes Care · doi:10.2337/dc10-0760 · Cited by 141
Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study
Honka, M.-J., Latva-Rasku, A., Bucci, M., Virtanen, K. A., Hannukainen, J. C., Kalliokoski, K. K., & Nuutila, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0882 · Cited by 140
Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid
Yang, Y. M., Seo, S. Y., Kim, T. H., & Kim, S. G. (2012) · Hepatology · doi:10.1002/hep.25912 · Cited by 140
Resveratrol and obesity: can resveratrol relieve metabolic disturbances?
de Ligt, M., Timmers, S., & Schrauwen, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.012 · Cited by 135
Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity — A randomized trial
Winn, N. C., Liu, Y., Rector, R. S., Parks, E. J., Ibdah, J. A., & Kanaley, J. A. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.012 · Cited by 138
Decreased Adipose Tissue Oxygenation Associates with Insulin Resistance in Individuals with Obesity
Cifarelli, V., Beeman, S. C., Smith, G. I., Yoshino, J., Morozov, D., Beals, J. W., Kayser, B. D., Watrous, J. D., Jain, M., Patterson, B. W., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141828 · Cited by 132
Self-citation
Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function
Funai, K., Lodhi, I. J., Spears, L. D., Yin, L., Song, H., Klein, S., & Semenkovich, C. F. (2015) · Diabetes · doi:10.2337/db15-0659 · Cited by 132
Self-citation
Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
Salomone, F., Galvano, F., Cappello, F., Mangiameli, A., Barbagallo, I. A., & Volti, G. L. (2012) · Translational research · doi:10.1016/j.trsl.2011.12.003 · Cited by 131
CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis
Tomita, K., Freeman, B. L., Bronk, S. F., LeBrasseur, N. K., White, T. A., Hirsova, P., & Ibrahim, S. H. (2016) · Scientific Reports · doi:10.1038/srep28786 · Cited by 130
Contribution of specific ceramides to obesity-associated metabolic diseases
Hammerschmidt, P., & Brüning, J. C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04401-3 · Cited by 133
Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease
Bonekamp, S., Tang, A., Mashhood, A., Wolfson, T. J., Changchien, C., Middleton, M. S., Clark, L., Gamst, A. C., Loomba, R. S., & Sirlin, C. B. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24321 · Cited by 127
Green Tea Extract Suppresses NFκB Activation and Inflammatory Responses in Diet-Induced Obese Rats with Nonalcoholic Steatohepatitis3
Park, H. J., Lee, J., Chung, M., Park, Y., Bower, A. M., Koo, S. I., Giardina, C. A., & Bruno, R. S. (2011) · Journal of Nutrition · doi:10.3945/jn.111.148544 · Cited by 127
Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men
van Herpen, N. A., Schrauwen-Hinderling, V. B., Schaart, G., Mensink, R. P., & Schrauwen, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2243 · Cited by 124
Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia
Amaro, A., Fabbrini, E., Kars, M., Yue, P., Schechtman, K. B., Schonfeld, G., & Klein, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.039 · Cited by 124
Self-citation
Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia
Keating, S. E., Sabag, A., Hallsworth, K., Hickman, I. J., Macdonald, G. A., Stine, J. G., George, J., & Johnson, N. A. (2023) · Sports Medicine · doi:10.1007/s40279-023-01918-w · Cited by 119
The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
Grefhorst, A., van de Peppel, I. P., Larsen, L. E., Jonker, J. W., & Holleboom, A. G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.601627 · Cited by 122
Origins of metabolic complications in obesity
Mittendorfer, B. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834ad8b6 · Cited by 123
Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents
Deivanayagam, S., Mohammed, B. S., Vitola, B. E., Naguib, G., Keshen, T. H., Kirk, E. P., & Klein, S. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.2.257 · Cited by 117
Self-citation
Genetics of nonalcoholic fatty liver disease
Dongiovanni, P., & Valenti, L. V. C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.018 · Cited by 118
Does fructose consumption contribute to non-alcoholic fatty liver disease?
Tappy, L., & Lê, K. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.06.005 · Cited by 117
Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption
Sanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1439-8 · Cited by 114
Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease
Croci, I., Byrne, N. M., Choquette, S., Hills, A. P., Chachay, V., Clouston, A. D., O'Moore‐Sullivan, T. M., Macdonald, G. A., Prins, J. B., & Hickman, I. J. (2012) · Gut · doi:10.1136/gutjnl-2012-302789 · Cited by 119
Adipose tissue in health and disease
Harvey, I. C., Boudreau, A., & Stephens, J. M. (2020) · Open Biology · doi:10.1098/rsob.200291 · Cited by 126
Insulin-sensitive obesity in humans – a ‘favorable fat’ phenotype?
Samocha‐Bonet, D., Chisholm, D. J., Tonks, K. T. T., Campbell, L. V., & Greenfield, J. R. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.005 · Cited by 110
Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
Pihlajamäki, J., Kuulasmaa, T., Kamińska, D., Simonen, M., Kärjä, V. J., Grönlund, S., Käkelä, P., Pääkkönen, M. E., Kainulainen, S., Punnonen, K. R. A., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.005 · Cited by 109
p53 Functions in Adipose Tissue Metabolism and Homeostasis
Krstić, J., Reinisch, I., Schupp, M., Schulz, T. J., & Prokesch, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092622 · Cited by 110
The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: A systematic review and meta-analysis
Sargeant, J. A., Gray, L. J., Bodicoat, D. H., Willis, S. A., Stensel, D. J., Nimmo, M. A., Aithal, G. P., & King, J. A. (2018) · Obesity Reviews · doi:10.1111/obr.12719 · Cited by 105
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study
Bell, L. N., Wang, J., Muralidharan, S. S., Chalasani, S., Fullenkamp, A. M., Wilson, L., Sanyal, A. J., Kowdley, K. V., Neuschwander‐Tetri, B. A., Brunt, E. M., et al. (2012) · Hepatology · doi:10.1002/hep.25805 · Cited by 106
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2170-0 · Cited by 104
The Impact of Exercise Training Compared to Caloric Restriction on Hepatic and Peripheral Insulin Resistance in Obesity
Coker, R. H., Williams, R. H., Yeo, S. E., KORTEBEIN, P. M., Bodenner, D. L., Kern, P. A., & Evans, W. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2033 · Cited by 102
The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection
Lake, J. E. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0368-6 · Cited by 102
Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy
Brown, R. J., Valencia, A., Startzell, M. S., Cochran, E. K., Walter, P. J., Garraffo, H. M., Cai, H., Gharib, A. M., Ouwerkerk, R., Courville, A. B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95476 · Cited by 102
Androgen Deficiency Exacerbates High-Fat Diet-Induced Metabolic Alterations in Male Mice
Dubois, V., Laurent, M. R., Jardí, F., Antonio, L., Lemaire, K., Goyvaerts, L., Deldicque, L., Carmeliet, G., Decallonne, B., Vanderschueren, D., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1713 · Cited by 102
Multiorgan insulin sensitivity in lean and obese subjects
Conte, C., Fabbrini, E., Kars, M., Mittendorfer, B., Patterson, B. W., & Klein, S. (2012) · Diabetes Care · doi:10.2337/dc11-1951 · Cited by 99
Self-citation
Endoplasmic Reticulum Stress and the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
Gentile, C. L., Frye, M. A., & Pagliassotti, M. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3790 · Cited by 100
Increased Whole‐Body Adiposity Without a Concomitant Increase in Liver Fat is Not Associated With Augmented Metabolic Dysfunction
Magkos, F., Fabbrini, E., Mohammed, B. S., Patterson, B. W., & Klein, S. (2010) · Obesity · doi:10.1038/oby.2010.90 · Cited by 97
Self-citation
Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis
Heier, E.-C., Meier, A., Julich-Haertel, H., Djudjaj, S., Rau, M., Tschernig, T., Geier, A., Boor, P., Lammert, F., & Lukacs-Kornek, V. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.008 · Cited by 94
Alterations in Fatty Acid Kinetics in Obese Adolescents With Increased Intrahepatic Triglyceride Content
Fabbrini, E., DeHaseth, D., Deivanayagam, S., Mohammed, B. S., Vitola, B. E., & Klein, S. (2008) · Obesity · doi:10.1038/oby.2008.494 · Cited by 94
Self-citation
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD
Meroni, M., Longo, M., Fracanzani, A. L., & Dongiovanni, P. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102866 · Cited by 92
Beneficial effects of Undaria pinnatifida ethanol extract on diet-induced-insulin resistance in C57BL/6J mice
Park, H., Lee, M., Park, Y. B., Shin, Y. C., & Choi, M. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.11.032 · Cited by 91
A Low-Glycemic-Load versus Low-Fat Diet in the Treatment of Fatty Liver in Obese Children
Ramon‐Krauel, M., Salsberg, S., Ebbeling, C. B., Voss, S. D., Mulkern, R. V., Apura, M. M., Cooke, E. A., Sarao, K., Jonas, M. M., & Ludwig, D. S. (2013) · Childhood Obesity · doi:10.1089/chi.2013.0022 · Cited by 94
Inhibitory cross‐talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress‐induced insulin resistance in skeletal muscle
Hwang, S., Jeong, Y., Li, X., Kim, Y. D., Lu, Y., Chang, Y., Lee, I., & Chang, H. W. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12124 · Cited by 92
The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals
Nishioji, K., Mochizuki, N., Kobayashi, M., Kamaguchi, M., Sumida, Y., Nishimura, T., Yamaguchi, K., Kadotani, H., & Itoh, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140427 · Cited by 87
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
Ahadi, M., Molooghi, K., Masoudifar, N., Namdar, A. B., Vossoughinia, H., & Farzanehfar, M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15353 · Cited by 94
Adipose tissue monomethyl branched-chain fatty acids and insulin sensitivity: Effects of obesity and weight loss
Su, X., Magkos, F., Zhou, D., Eagon, J. C., Fabbrini, E., Okunade, A. L., & Klein, S. (2014) · Obesity · doi:10.1002/oby.20923 · Cited by 91
Self-citation
Effects of physical activity upon the liver
Shephard, R. J., & Johnson, N. A. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-3031-6 · Cited by 93
Hibernation induces widespread transcriptional remodeling in metabolic tissues of the grizzly bear
Jansen, H. T., Trojahn, S., Saxton, M. W., Quackenbush, C. R., Hutzenbiler, B. D. E., Nelson, O. L., Cornejo, O. E., Robbins, C. T., & Kelley, J. L. (2019) · Communications Biology · doi:10.1038/s42003-019-0574-4 · Cited by 94
Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles
Bravo, S., Lowndes, J., Sinnett, S., Yu, Z., & Rippe, J. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0322 · Cited by 86
Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis
Zhang, M., Chi, X., Qu, N., & Wang, C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.127 · Cited by 85
Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease
Rodríguez‐Gallego, E., Guirro, M., Riera-Borrull, M., Hernández‐Aguilera, A., Mariné-Casadó, R., Fernández‐Arroyo, S., Beltrán‐Debón, R., Sabench, F., Hernández, M., Castillo, D. D., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.53 · Cited by 84
Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients
Bortolotti, M., Maiolo, E. M., Corazza, M., Dijke, E. V., Schneiter, P., Boss, A., Carrel, G., Giusti, V., Lê, K., Chong, D. G., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.01.006 · Cited by 83
Weight Loss Reduces Liver Fat and Improves Hepatic and Skeletal Muscle Insulin Sensitivity in Obese Adolescents
Vitola, B. E., Deivanayagam, S., Stein, R. I., Mohammed, B. S., Magkos, F., Kirk, E. P., & Klein, S. (2009) · Obesity · doi:10.1038/oby.2009.171 · Cited by 81
Self-citation
Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease
Westerbacka, J., Kotronen, A., Fielding, B. A., Wahren, J., Hodson, L., Perttilä, J., Seppänen‐Laakso, T., Suortti, T., Arola, J. T., Hultcrantz, R. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.064 · Cited by 79
Nonalcoholic Fatty Liver Disease
Law, K., & Brunt, E. M. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.07.006 · Cited by 77
Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics
Smith, G. I., Polidori, D. C., Yoshino, M., Kearney, M. L., Patterson, B. W., Mittendorfer, B., & Klein, S. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136756 · Cited by 78
Self-citation
Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis
Salomone, F., Galvano, F., Marino, A., Paternostro, C., Tibullo, D., Bucchieri, F., Mangiameli, A., Parola, M., Bugianesi, E., & Volti, G. L. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.11.010 · Cited by 73
Gastrointestinal complications of obesity: Non-alcoholic fatty liver disease (NAFLD) and its sequelae
Karlas, T., Wiegand, J., & Berg, T. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.002 · Cited by 74
Implications of diet on nonalcoholic fatty liver disease
Sullivan, S. A. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283358a58 · Cited by 72
Basal very low-density lipoprotein metabolism in response to exercise: Mechanisms of hypotriacylglycerolemia
Magkos, F. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.02.003 · Cited by 71
Long-Lasting Improvements in Liver Fat and Metabolism Despite Body Weight Regain After Dietary Weight Loss
Haufe, S., Haas, V. K., Utz, W., Birkenfeld, A. L., Jeran, S., Böhnke, J., Mähler, A., Luft, F. C., Schulz‐Menger, J., Boschmann, M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0102 · Cited by 73
Phenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity
Chen, D., Liess, C., Poljak, A., Xu, A., Zhang, J.-L., Thoma, C., Trenell, M. I., Milner, B., Jenkins, A. B., Chisholm, D. J., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2712 · Cited by 73
Exercise training reduces intrahepatic lipid content in people with and people without nonalcoholic fatty liver
Brouwers, B., Schrauwen‐Hinderling, V. B., Jeleník, T., Gemmink, A., Sparks, L. M., Havekes, B., Bruls, Y. M. H., Dahlmans, D., Roden, M., Hesselink, M. K. C., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2017 · Cited by 68
A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies
von Loeffelholz, C., Coldewey, S. M., & Birkenfeld, A. L. (2021) · Cells · doi:10.3390/cells10071822 · Cited by 70
Nonalcoholic Fatty Liver Disease
Paredes, A. H., Torres, D. M., & Harrison, S. A. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.005 · Cited by 72
Moroorange juice prevents fatty liver in mice
Salomone, F. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i29.3862 · Cited by 80
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
Visser, M. E., Lammers, N. M., Nederveen, A. J., van der Graaf, M., Heerschap, A., Ackermans, M. T., Sauerwein, H. P., Stroes, E. S. G., & Serlie, M. J. M. (2011) · Diabetologia · doi:10.1007/s00125-011-2157-x · Cited by 71
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes
Käräjämäki, A. J., Bloigu, R., Kauma, H., Kesäniemi, Y. A., Koivurova, O., Perkiömäki, J. S., Huikuri, H. V., & Ukkola, O. H. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.009 · Cited by 68
The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Nie, Q., Li, M., Huang, C., Yongwei, Y., Liang, Q., Ma, X., Qiu, T., & Li, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05011-2 · Cited by 65
Alterations in Ventricular Structure and Function in Obese Adolescents with Nonalcoholic Fatty Liver Disease
Singh, G. K., Vitola, B. E., Holland, M. R., Sekarski, T. J., Patterson, B. W., Magkos, F., & Klein, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.11.024 · Cited by 65
Self-citation
Fructose-Containing Sugars and Cardiovascular Disease
Rippe, J. M., & Angelopoulos, T. J. (2015) · Advances in Nutrition · doi:10.3945/an.114.008177 · Cited by 66
Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
Allison, M., Griffin, J. L., Vacca, M., & Vidal‐Puig, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562945 · Cited by 67
Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
Hodson, L., Bhatia, L. S., Scorletti, E., Smith, D. E., Jackson, N. C., Shojaee‐Moradie, F., Umpleby, A. M., Calder, P. C., & Byrne, C. D. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.9 · Cited by 63
Dietary weight loss-induced improvements in metabolic function are enhanced by exercise in people with obesity and prediabetes
Beals, J. W., Kayser, B. D., Smith, G. I., Schweitzer, G. G., Kirbach, K., Kearney, M. L., Yoshino, J., Rahman, G., Knight, R. D., Patterson, B. W., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00829-4 · Cited by 68
Self-citation
MECHANISMS IN ENDOCRINOLOGY: Pathogenesis of type 2 diabetes in South Asians
Bakker, L. E. H., Sleddering, M. A., Schoones, J. W., Meinders, A. E., & Jazet, I. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0307 · Cited by 63
Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion
D’Adamo, E., Northrup, V. S., Weiss, R., Santoro, N., Pierpont, B. M., Savoye, M., O’Malley, G., & Caprio, S. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29270 · Cited by 62
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
Bai, J., Xia, M., Xue, Y., Ma, F., Cui, A., Sun, Y., Han, Y., Xu, X., Zhang, F., Hu, Z., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102849 · Cited by 62
Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease
Beals, J. W., Smith, G. I., Shankaran, M., Fuchs, A. G., Schweitzer, G. G., Yoshino, J., Field, T., Matthews, M. D., Nyangau, E., Morozov, D., et al. (2021) · Hepatology · doi:10.1002/hep.31822 · Cited by 64
Self-citation
Insulin sensitivity is not associated with palmitoleate availability in obese humans
Fabbrini, E., Magkos, F., Su, X., Abumrad, N. A., Nejedly, N. L., Coughlin, C. C., Okunade, A. L., Patterson, B. W., & Klein, S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m013599 · Cited by 61
Self-citation
Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy
Guiu, B., Loffroy, R., Petit, J., Aho, S., Salem, D. B., Masson, D., Hillon, P., Cercueil, J., & Krause, D. (2009) · European Radiology · doi:10.1007/s00330-009-1330-9 · Cited by 60
Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P. (2017) · Clinical Science · doi:10.1042/cs20170261 · Cited by 59
Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention
Otten, J., Mellberg, C., Ryberg, M., Sandberg, S., Kullberg, J., Lindahl, B., Larsson, C. L., Hauksson, J. B., & Olsson, T. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.4 · Cited by 60
The role of hepatic lipid composition in obesity‐related metabolic disease
Willis, S. A., Bawden, S., Malaikah, S., Sargeant, J. A., Stensel, D. J., Aithal, G. P., & King, J. A. (2021) · Liver International · doi:10.1111/liv.15059 · Cited by 63
Nonalcoholic fatty liver disease and vascular risk
Bhatia, L. S., Curzen, N. P., & Byrne, C. D. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328354829c · Cited by 58
Non‐alcoholic fatty liver disease
Tuyama, A. C., & Chang, C. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00204.x · Cited by 58
High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths
Chiara, F. D., Checcllo, C. U., & Ramón‐Azcón, J. (2019) · Nutrients · doi:10.3390/nu11122985 · Cited by 58
Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
Azevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 59
Current strategies for the inhibition of hepatic glucose production in type 2 diabetes
Dale, S. E. (2009) · Frontiers in bioscience · doi:10.2741/3301 · Cited by 55
Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo
Wang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 55
Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis
Posadas‐Romero, C., Galarza, E. J., Posadas‐Sánchez, R., Acuña-Valerio, J., Juárez-Rojas, J. G., Kimura‐Hayama, E., Medina-Urrutia, A. X., & Cardoso-Saldaña, G. C. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0150 · Cited by 55
A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity
Geisler, C. E., Ghimire, S., Bruggink, S. M., Miller, K. E., Weninger, S. N., Kronenfeld, J. M., Yoshino, J., Klein, S., Duca, F. A., & Renquist, B. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109301 · Cited by 59
Self-citation
Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humansin vivo
Magkos, F., & Mittendorfer, B. (2009) · Clinical Lipidology · doi:10.2217/clp.09.9 · Cited by 54
Cardiorespiratory Fitness and Insulin Sensitivity in Overweight or Obese Subjects May Be Linked Through Intrahepatic Lipid Content
Haufe, S., Engeli, S., Budziarek, P., Utz, W., Schulz‐Menger, J., Hermsdorf, M., Wiesner, S., Otto, C., Haas, V. K., de Greiff, A., et al. (2010) · Diabetes · doi:10.2337/db09-1200 · Cited by 55
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue‐specific insulin sensitivity in patients with early‐stage type 2 diabetes with non‐alcoholic fatty liver disease: A prospective randomized study
Hiruma, S., Shigiyama, F., & Kumashiro, N. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15006 · Cited by 54
Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH
Mucinski, J. M., Salvador, A. F., Moore, M. P., Fordham, T. M., Anderson, J. M., Shryack, G. E., Cunningham, R. P., Lastra, G., Gaballah, A. H., Diaz‐Arias, A. A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.017 · Cited by 58
Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes
Barchetta, I., Cimini, F. A., Leonetti, F., Capoccia, D., Cristofano, C. D., Silecchia, G., Orho‐Melander, M., Melander, O., & Cavallo, M. G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02751 · Cited by 54
Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis
Yang, Y., Xie, L. H., Zhang, N., Zhou, D., Liu, T., & Wu, J. H. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00860-3 · Cited by 53
Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus
Lempesis, I. G., & Georgakopoulou, V. (2023) · World Journal of Experimental Medicine · doi:10.5493/wjem.v13.i3.7 · Cited by 58
Anti-obesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet
Yamamoto, N., Kanemoto, Y., Ueda, M., Kawasaki, K., Fukuda, I., & Ashida, H. (2011) · Food Funct. · doi:10.1039/c0fo00129e · Cited by 52
Ashitaba (Angelica keiskei) extract prevents adiposity in high-fat diet-fed C57BL/6 mice
Zhang, T., Yamashita, Y., Yasuda, M. T., Yamamoto, N., & Ashida, H. (2014) · Food & Function · doi:10.1039/c4fo00525b · Cited by 52

Authors: Korenblat, K. M., Fabbrini, E., Mohammed, B. S., & Klein, S.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Klein, Samuel
ORCID: Korenblat, Kevin M.
Fabbrini, Elisa
Klein, Samuel
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2008-05
Volume: 134
Issue: 5
Pages: 1369-1375
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2008.01.075
PMC: PMC2629391
OpenAlex: W2071867050
Semantic Scholar: 583ea7ff89ae3ebd20b01708b92228e15c0f7b02
Cited by: 592
References: 41
Citations by year: 2026: 14 · 2025: 20 · 2024: 31 · 2023: 40 · 2022: 36 · 2021: 32 · 2020: 21 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 32 · 2015: 32 · 2014: 36 · 2013: 38 · 2012: 44
FWCI: 30.68
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders: National Institutes of Health (DK 37948, DK 56341, RR-00954, RR-00036)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords: intrahepatic triglyceride, insulin resistance, non-alcoholic fatty liver disease, hepatic insulin sensitivity, skeletal muscle glucose uptake, adipose tissue lipolysis, glucose production, obesity
MeSH terms: Adipose Tissue, Adult, Energy Metabolism, Female, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Magnetic Resonance Spectroscopy, Obesity, Prognosis, Risk Factors, Triglycerides, Glucose Clamp Technique, Biomarkers, Absorptiometry, Photon, Body Mass Index, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks